Clinical trial
Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone…
NCT00002987 · Medical Research Council, Other · Unknown status
Key facts
| NCT number | NCT00002987 |
|---|---|
| Title | Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease |
| Official title | Minimal Initial Therapy (MIT) for "Early" Supradiaphragmatic Hodgkin's Disease: A Multicenter Randomized Trial of Short Neoadjuvant Chemotherapy (VAPEC-B) Plus Involved Field Radiotherapy (MIT) Versus Mantle Radiotherapy |
| Lead sponsor | Medical Research Council, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Radiation |
| Interventions | bleomycin sulfate, cyclophosphamide, doxorubicin hydrochloride, etoposide, prednisolone, vincristine sulfate, radiation therapy |
| Enrollment | 400 |
| Start date | Jan 1, 1997 |
| First posted | Apr 6, 2004 |
| Last update posted | Dec 4, 2013 |
| Countries | South Africa, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: